Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KRRO Korro Bio, Inc.

已收盘 11-26 16:00:00 EST

53.25

+1.25

+2.40%

盘后53.25

+0.000.00%

16:20 EST

最高56.69	最低48.71	成交量5.93万
今开51.62	昨收52.00	日振幅15.34%
总市值4.99亿	流通市值2.36亿	总股本936.83万
成交额319.40万	换手率1.34%	流通股本443.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KRRO","market":"US","secType":"STK","nameCN":"Korro Bio, Inc.","latestPrice":53.25,"timestamp":1732654800000,"preClose":52,"halted":0,"volume":59288,"hourTrading":{"tag":"盘后","latestPrice":53.25,"preClose":53.25,"latestTime":"16:20 EST","volume":441,"amount":23483.25,"timestamp":1732656000724},"delay":0,"floatShares":4437424,"shares":9368262,"eps":-11.11486,"marketStatus":"已收盘","marketStatusCode":5,"change":1.25,"latestTime":"11-26 16:00:00 EST","open":51.62,"high":56.6898,"low":48.7145,"amount":3193952.582736,"amplitude":0.153371,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.11486,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732698000000},"adr":0,"listingDate":1570075200000,"adjPreClose":52,"preHourTrading":{"tag":"盘前","latestPrice":52.5,"preClose":52,"latestTime":"08:14 EST","volume":261,"amount":13034.090745,"timestamp":1732626853556},"postHourTrading":{"tag":"盘后","latestPrice":53.25,"preClose":53.25,"latestTime":"16:20 EST","volume":441,"amount":23483.25,"timestamp":1732656000724},"volumeRatio":0.613171},"requestUrl":"/m/hq/s/KRRO/tweets","defaultTab":"tweets","newsList":[{"id":"2486004227","title":"Korro Bio, Inc.盘中异动 早盘股价大跌6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486004227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486004227?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:32","pubTimestamp":1732631576,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时32分，Korro Bio, Inc.股票出现波动，股价快速下跌6.32%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223256abe0bd06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223256abe0bd06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2485261961","title":"Korro Bio, Inc.盘中异动 大幅拉升7.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261961?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:37","pubTimestamp":1732286248,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时37分，Korro Bio, Inc.股票出现异动，股价急速上涨7.96%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223728971a81a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223728971a81a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2485497459","title":"Korro Bio, Inc.盘中异动 早盘股价大涨6.23%报49.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497459?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:42","pubTimestamp":1732200134,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时42分，Korro Bio, Inc.股票出现波动，股价快速拉升6.23%。截至发稿，该股报49.93美元/股，成交量1250股，换手率0.01%，振幅2.39%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224214a24b7a64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121224214a24b7a64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2484110885","title":"Korro Bio, Inc.盘中异动 急速拉升5.35%报49.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110885?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:37","pubTimestamp":1732113452,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时37分，Korro Bio, Inc.股票出现异动，股价快速拉升5.35%。截至发稿，该股报49.12美元/股，成交量1599股，换手率0.02%，振幅0.00%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223732a248c4e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223732a248c4e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2484591534","title":"Korro Bio, Inc.2024财年第三财季实现净利润-21.00百万美元，同比减少80.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484591534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484591534?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010430,"startTime":"0","endTime":"0","summary":"11月19日，Korro Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.00百万美元，同比减少80.88%；其中营业收入为0.00美元，每股基本收益为-2.26美元。从资产负债表来看，Korro Bio, Inc.总负债63.91百万美元，其中短期债务0.00美元，资产负债比为0.04，流动比率为0.12。机构评级：截至2024年11月19日，当前有6家机构对Korro Bio, Inc.目标价做出预测，其中目标均价为133.83美元，其中最低目标价为105.00美元，最高目标价为180.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180151abcedf7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180151abcedf7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO"],"gpt_icon":0},{"id":"2484676417","title":"Korro Bio, Inc.盘中异动 早盘大幅拉升5.40%报50.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676417?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:39","pubTimestamp":1731940747,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时39分，Korro Bio, Inc.股票出现波动，股价大幅上涨5.40%。截至发稿，该股报50.13美元/股，成交量7048股，换手率0.08%，振幅5.05%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223907971a72cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223907971a72cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2484661939","title":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661939","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661939?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:15","pubTimestamp":1731914144,"startTime":"0","endTime":"0","summary":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals路透11月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Airbnb、Post Holdings 和 Syndax Pharmaceuticals。* Post Holdings Inc POST.N：摩根大通将目标价从125美元上调至135美元 * Syndax Pharmaceuticals Inc SNDX.O：杰富瑞将目标价从37美元上调至43美元 * Transmedics Group Inc TMDX.O：TD Cowen将目标价从175美元下调至120美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4S3MP0GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TARS","HK0000306701.USD","LU1196710864.SGD","LU0737861772.HKD","IE00BFMHRM44.USD","LU0516422440.USD","SNDX","PGR","IE00BZ08YT58.USD","LU1688375341.USD","OVV","MBI","BABA","LU1983260115.SGD","LU0051755006.USD","LU1439103000.SGD","KRRO","LU0251144936.SGD","89988","BK4503","IE00BZ08YR35.GBP","PCOR","LU1023057109.AUD","LU0543330566.HKD","POST","CAPR","BK1502","LU2355687059.USD","LU1048588211.SGD","LU0898667661.SGD","TMDX","ADSK","LU0345776255.USD","09988","IE00B19Z9Z06.USD","PLD","BK1521","LU0228367735.SGD","LU0287142896.SGD","LU0543330483.HKD","LU1105468828.SGD","ABNB","LU1481107354.HKD","HBBD.SI","EFXT","INO","LU0293314216.USD","LU0348788117.USD","LU0541502299.USD","YELP"],"gpt_icon":1},{"id":"2483882440","title":"Korro Bio, Inc.盘中异动 早盘股价大涨7.15%报69.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882440?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:47","pubTimestamp":1731509273,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时47分，Korro Bio, Inc.股票出现波动，股价急速上涨7.15%。截至发稿，该股报69.80美元/股，成交量4458股，换手率0.05%，振幅4.94%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322475498e42614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322475498e42614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2482085770","title":"Korro Bio, Inc.盘中异动 大幅下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085770?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:39","pubTimestamp":1731422344,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时39分，Korro Bio, Inc.股票出现波动，股价急速下挫5.20%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223904971a602d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223904971a602d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2482738116","title":"Korro Bio, Inc.盘中异动 股价大跌5.45%报66.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738116?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:34","pubTimestamp":1731335656,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时34分，Korro Bio, Inc.股票出现波动，股价急速下挫5.45%。截至发稿，该股报66.56美元/股，成交量3046股，换手率0.03%，振幅5.45%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122341795be10ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122341795be10ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2481210058","title":"Korro Bio, Inc.盘中异动 早盘大幅拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481210058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481210058?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:15","pubTimestamp":1731078939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时15分，Korro Bio, Inc.股票出现异动，股价急速拉升5.24%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231539abae5674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231539abae5674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2481964309","title":"Korro Bio Inc 预计每股亏损 2.61 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481964309","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481964309?lang=zh_cn&edition=full","pubTime":"2024-11-07 07:21","pubTimestamp":1730935319,"startTime":"0","endTime":"0","summary":"Korro Bio Inc 预计每股亏损 2.61 美元 - 财报前瞻Korro Bio Inc KRRO.OQ KRRO.O将于11月8日公布截至2024年9月30日的财报 LSEG 的分析师平均预计 Korro Bio Inc 每股亏损 2.61 美元。华尔街对 Korro Bio Inc 的 12 个月目标价中位数为 120.00 美元，高于其上次收盘价 66.63 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD3LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2480708584","title":"Korro Bio, Inc.盘中异动 早盘大幅跳水5.26%报55.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480708584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480708584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731023,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Korro Bio, Inc.股票出现异动，股价急速跳水5.26%。截至发稿，该股报55.10美元/股，成交量4644股，换手率0.05%，振幅5.69%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223703ab9ec0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223703ab9ec0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2480593690","title":"Korro Bio, Inc.盘中异动 下午盘股价大跌5.03%报57.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480593690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480593690?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:00","pubTimestamp":1730394005,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时00分，Korro Bio, Inc.股票出现异动，股价快速下挫5.03%。截至发稿，该股报57.79美元/股，成交量6.4047万股，换手率0.69%，振幅5.37%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.69%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110101000598e3fc66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110101000598e3fc66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2479200250","title":"Korro Bio Inc   预计每股亏损 2.61 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479200250","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479200250?lang=zh_cn&edition=full","pubTime":"2024-10-30 05:05","pubTimestamp":1730235951,"startTime":"0","endTime":"0","summary":"   * Korro Bio Inc    预计在10月31日发布业绩报告时，季度营收将没有变化(预计)，截至2024年9月30日。*    * LSEG 的分析师平均预计 Korro Bio Inc 每股亏损 2.61 美元。* 华尔街对 Korro Bio Inc 的 12 个月目标价中位数为 120.00 美元，高于其上次收盘价 63.85 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Korro Bio Inc   预计每股亏损 2.61 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRRO"],"gpt_icon":0},{"id":"2479023210","title":"Korro Bio, Inc.盘中异动 股价大涨5.36%报67.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479023210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479023210?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:44","pubTimestamp":1730223842,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日01时44分，Korro Bio, Inc.股票出现异动，股价快速拉升5.36%。截至发稿，该股报67.27美元/股，成交量1.7453万股，换手率0.19%，振幅4.92%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030014403a1f6360f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030014403a1f6360f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRRO","BK4139"],"gpt_icon":0},{"id":"2478435890","title":"Korro Bio, Inc.盘中异动 临近午盘急速下挫5.25%报64.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478435890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478435890?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:33","pubTimestamp":1730129600,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时33分，Korro Bio, Inc.股票出现异动，股价快速下挫5.25%。截至发稿，该股报64.58美元/股，成交量2.1067万股，换手率0.23%，振幅6.56%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823332098e3edf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823332098e3edf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2478093256","title":"Korro Bio, Inc.盘中异动 早盘急速上涨5.12%报71.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478093256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478093256?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:50","pubTimestamp":1729867841,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时50分，Korro Bio, Inc.股票出现异动，股价大幅拉升5.12%。截至发稿，该股报71.62美元/股，成交量2.6474万股，换手率0.28%，振幅5.03%。Korro Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522504198e3e889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522504198e3e889&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2477362074","title":"Korro Bio, Inc.盘中异动 临近收盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477362074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477362074?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:40","pubTimestamp":1729626022,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时40分，Korro Bio, Inc.股票出现波动，股价快速下挫5.18%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303402298e3dd46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102303402298e3dd46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0},{"id":"2477386585","title":"Korro Bio, Inc.盘中异动 早盘股价大涨6.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477386585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477386585?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517473,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Korro Bio, Inc.股票出现波动，股价快速拉升6.20%。Korro Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Korro Bio, Inc.公司简介：Korro Bio Inc 是一家生物制药公司，其使命是发现、开发和商业化一类基于编辑RNA的新型基因药物，使罕见和高度流行疾病的治疗成为可能。通过编辑RNA而不是DNA, Korro Bio正在通过提供额外的精度和可调性来扩大基因药物的应用范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213113a1e2492f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213113a1e2492f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRRO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://korrobio.com","stockEarnings":[{"period":"1week","weight":0.1152},{"period":"1month","weight":-0.237},{"period":"3month","weight":0.0463},{"period":"6month","weight":0.0402},{"period":"1year","weight":0.3588},{"period":"ytd","weight":0.0849}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Korro Bio, Inc.是一家特拉华州公司。Korro Bio是一家生物制药公司，其使命是发现、开发和商业化一种基于编辑RNA的新型基因药物，从而能够治疗罕见和高度流行的疾病。Korro Bio正在开发一系列差异化程序，旨在利用人体的自然RNA编辑过程，实现精确而短暂的单碱基编辑。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.151165},{"month":2,"riseRate":0.2,"avgChangeRate":-0.240548},{"month":3,"riseRate":0.2,"avgChangeRate":-0.127032},{"month":4,"riseRate":0.2,"avgChangeRate":-0.169505},{"month":5,"riseRate":0.2,"avgChangeRate":-0.085733},{"month":6,"riseRate":0.6,"avgChangeRate":0.073242},{"month":7,"riseRate":0.6,"avgChangeRate":0.186094},{"month":8,"riseRate":0.4,"avgChangeRate":-0.032825},{"month":9,"riseRate":0,"avgChangeRate":-0.150423},{"month":10,"riseRate":0.4,"avgChangeRate":0.072833},{"month":11,"riseRate":0.666667,"avgChangeRate":0.493935},{"month":12,"riseRate":1,"avgChangeRate":0.232406}],"exchange":"NASDAQ","name":"Korro Bio, Inc.","nameEN":"Korro Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Korro Bio, Inc.,KRRO,Korro Bio, Inc.股票,Korro Bio, Inc.股票老虎,Korro Bio, Inc.股票老虎国际,Korro Bio, Inc.行情,Korro Bio, Inc.股票行情,Korro Bio, Inc.股价,Korro Bio, Inc.股市,Korro Bio, Inc.股票价格,Korro Bio, Inc.股票交易,Korro Bio, Inc.股票购买,Korro Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Korro Bio, Inc.(KRRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Korro Bio, Inc.(KRRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}